Back |
home / stock / tara / tara message board
Subject | By | Source | When |
---|---|---|---|
Boat load of cash in the coffers | dinogreeves | investorshub | 07/28/2020 1:23:26 PM |
Under 800,000 float. | dinogreeves | investorshub | 07/28/2020 1:02:26 PM |
TARA could be heading for a 100-200% move today. | dinogreeves | investorshub | 07/28/2020 1:01:53 PM |
$TARA: Back to $34.68 | makinezmoney | investorshub | 01/23/2020 3:41:17 PM |
$TARA: ex-$PRTO ... heading up to $60 | makinezmoney | investorshub | 01/22/2020 7:08:42 PM |
znewcar1: PRTO 28% v3,9M c.8352 f22M H.955 S.665 | znewcar1 | investorshangout | 01/09/2020 9:59:54 PM |
znewcar1: PRTO 22% v694K c.4401 f22M H .441 | znewcar1 | investorshangout | 12/30/2019 9:40:56 PM |
znewcar1: PRTO 50% v19,7M c.6234 f19M H.71 nice late morning BO. | znewcar1 | investorshangout | 05/23/2019 3:45:18 AM |
znewcar1: PRTO 50% v19,7M c.6234 f19M H .71 interesting | znewcar1 | investorshangout | 05/23/2019 3:41:10 AM |
znewcar1: PRTO 19% v1,M c.4490 f19M big gap from $.6-1.4 | znewcar1 | investorshangout | 05/21/2019 4:02:46 AM |
znewcar1: 21.62% v118,077 c2.2500 f19,221,292 sold trading day! | znewcar1 | investorshangout | 12/28/2018 9:36:21 PM |
PoemStone: $PRTO at resistance $2.50 Nasdaq GM | PoemStone | investorshangout | 06/10/2018 8:35:09 PM |
znewcar1: Gap fill ~100%? idk, I don't see news, there was suppose to be 4qtr results yet I don't se | znewcar1 | investorshangout | 03/21/2018 1:38:23 AM |
News, Short Squeeze, Breakout and More Instantly...
ArTara Therapeutics Inc. Company Name:
TARA Stock Symbol:
NASDAQ Market:
ArTara Therapeutics Inc. Website:
NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the grant of inducement non-qualified stock options to purchase an aggregate of 118,40...
NEW YORK, May 21, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will participate in a virtual fireside chat at the TD Cowen 5t...
Reported positive data from three-month evaluable CIS patients treated across ongoing TARA-002 clinical program in NMIBC Preliminary data from six-month evaluable patients in ADVANCED-2 trial of TARA-002 in NMIBC expected in 2H 2024 Reached alignment with FDA on registrational p...